Claire Xu, MD, PhD
Dr. Xu is NovaBridge’s Senior Vice President and Head of R&D COE, leading clinical development, clinical operation, clinical biomarker, project management and regulatory affairs. Dr. Xu joined I-Mab in 2018 as our U.S. site head, leading the establishment of I-Mab’s Maryland site and the continual growth of I-Mab’s clinical team. Previously, Dr. Xu held roles of increasing responsibility in Early Phase Development and Translational Medicine at Otsuka Pharmaceutical Development & Commercialization, where she was responsible for designing and overseeing multiple phase 1/2 studies of different therapeutic areas, including hematology/oncology. Dr. Xu received her PhD in clinical pharmacology from Indiana University School of Medicine and her Bachelor of Medicine degree from Zhongshan School of Medicine, Sun Yat-sen University, China.